Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis

scientific article

Phenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/IAI.73.3.1779-1787.2005
P932PMC publication ID1064965
P698PubMed publication ID15731079
P5875ResearchGate publication ID8002718

P2093author name stringW Zhao
S C Lee
A Casadevall
B C Fries
D L Goldman
R Kennan
P2860cites workAn alternative animal model for comparison of treatments for cryptococcal meningitisQ28369598
Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Q30424017
Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisoloneQ30449509
Effect of cytokines on anticryptococcal activity of human microglial cells.Q33655376
Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.Q33747538
Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolatesQ33877219
Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in miceQ33997697
Antibody interactions with the capsule of Cryptococcus neoformansQ34004832
Immunoregulation by capsular components of Cryptococcus neoformans.Q34155052
Pathogenesis of pulmonary Cryptococcus neoformans infection in the ratQ34543565
Phenotypic switching in Cryptococcus neoformansQ35005269
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitisQ35411136
The damage-response framework of microbial pathogenesisQ35709086
Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis.Q35773483
Chronic cryptococcal meningitis: a new experimental model in rabbitsQ35863351
THE FINE STRUCTURE OF CEREBRAL FLUID ACCUMULATION. IV. ON THE NATURE AND ORIGIN OF EXTRACELLULAR FLUIDS FOLLOWING CRYPTOCOCCAL POLYSACCHARIDE IMPLANTATION.Q35869877
Therapy for cryptococcal meningitis in patients with AIDSQ35997172
Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infectionQ36042949
Induction of Capsule Growth inCryptococcus neoformansby Mammalian Serum and CO2Q36376167
Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodentsQ36758698
Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformansQ36958708
Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndromeQ37298560
Raised intracranial pressure and visual complications in AIDS patients with cryptococcal meningitisQ38890373
Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucuronoxylomannan structureQ39512897
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passageQ39780336
Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibodyQ39822906
Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies.Q40007193
A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineageQ41183035
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapyQ43690816
Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implicationsQ44781962
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment GroupsQ45068097
Molecular subtypes and antifungal susceptibilities of serial Cryptococcus neoformans isolates in human immunodeficiency virus-associated Cryptococcosis. Cryptococcal Disease Active Surveillance GroupQ45767647
Comparison of the efficacy of amphotericin B and fluconazole in the treatment of cryptococcosis in human immunodeficiency virus-negative patients: retrospective analysis of 83 cases. French Cryptococcosis Study GroupQ45769494
A simple constant-infusion manometric test for measurement of CSF absorption: II. Clinical studiesQ47773570
Pathogenesis of cerebral Cryptococcus neoformans infection after fungemiaQ48500734
Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8.Q48570393
Cryptococcus neoformans meningitis in the rat.Q48848654
Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.Q52073846
Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune responseQ63247577
Pulmonary cryptococcosisQ70060077
Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study GroupQ71554754
Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitisQ73153700
Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for miceQ77552294
Acute respiratory failure associated with cryptococcosis in patients with AIDS: analysis of predictive factorsQ77595479
CRYPTOCOCCUS NEOFORMANS POLYSACCHARIDE: STUDIES OF SEROLOGIC PROPERTIES AND ROLE IN INFECTIONQ78467960
CryptococcosisQ78746513
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectCryptococcus neoformansQ131924
meningoencephalitisQ2346415
P304page(s)1779-1787
P577publication date2005-03-01
P1433published inInfection and ImmunityQ6029193
P1476titlePhenotypic switching of Cryptococcus neoformans can produce variants that elicit increased intracranial pressure in a rat model of cryptococcal meningoencephalitis
P478volume73

Reverse relations

cites work (P2860)
Q38259355Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans
Q36950154Allergen1 regulates polysaccharide structure in Cryptococcus neoformans
Q33505448Antigenic and phenotypic variations in fungi
Q41780353Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans
Q48807859Characterization of BBB permeability in a preclinical model of cryptococcal meningoencephalitis using magnetic resonance imaging.
Q38904619Cryptococcal Disease in HIV-Infected Children.
Q37395326Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis
Q41588074EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans
Q26801588Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis
Q36822539Histopathology of the arachnoid granulations and brain in HIV-associated cryptococcal meningitis: correlation with cerebrospinal fluid pressure
Q37033075Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans
Q37105673Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis.
Q37600634Phenotypic Switching in Fungi
Q57798551Phenotypic Variability Correlates with Clinical Outcome in Isolates Obtained from Botswanan HIV/AIDS Patients
Q36476671Phenotypic switching and its implications for the pathogenesis of Cryptococcus neoformans
Q82130569Phenotypic switching in Cryptococcus neoformans
Q37196293Phenotypic switching of Cryptococcus neoformans and Cryptococcus gattii
Q37742176Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis
Q41736221Ventriculoperitoneal shunts for treating increased intracranial pressure in cryptococcal meningitis with or without ventriculomegaly
Q37402023Virulence in Cryptococcus species

Search more.